[Guidelines on long-acting injectable atypical antipsychotics for first-episode schizophrenia].

Related Articles

[Guidelines on long-acting injectable atypical antipsychotics for first-episode schizophrenia].

Encephale. 2013 Sep;39 Suppl 2:S121-3

Authors: Azorin JM

Abstract
The current review raises the question of the place of long-acting injectable (LAI) atypical antipsychotics for the treatment of first-episode schizophrenia in current and future guidelines. After exposing the different points of view adopted in the former, the author presents the clinical trials conducted with LAI atypicals in this indication, as well as the surveys related to psychiatrists'opinion regarding the use of these drugs in early schizophrenia. Pros and cons of this therapeutic option are discussed and suggestions are made for further guidelines.

PMID: 24084422 [PubMed - indexed for MEDLINE]

Log In